The efficacy of human epidermal growth factor receptor 2 (HER2) blockade switching mode in refractory patients with HER2-positive metastatic breast cancer: A phase II, multicenter, single-arm study (SYSUCC-005)

Comparative efficacy and safety of different combinations of three CDK4/6 inhibitors with endocrine therapies in HR+/HER2−metastatic or advanced breast cancer patients: A network meta-analysis

12 p | 7 | 3

Efficacy and safety of nivolumab for advanced gastric cancer patients with poor performance statuses

6 p | 15 | 1

Efficacy of adjuvant chemotherapy stratified by age and the 21-gene recurrence score in estrogen receptorpositive breast cancer

10 p | 9 | 1

New evidence: Metformin unsuitable as routine adjuvant for breast cancer: A drugtarget mendelian randomization analysis

11 p | 1 | 1

Trastuzumab and fulvestrant combination therapy for women with advanced breast cancer positive for hormone receptor and human epidermal growth factor receptor 2: A retrospective single-center study

7 p | 14 | 0